Skip to main content
TipRanks
Go Ultimate75% OFF

Fevertree Drinks (FEVR) AI Stock Analysis

107 Followers
GB:FEVR

Fevertree Drinks

(LSE:FEVR)

Select Model
Rating:64Neutral
Price Target:GBX 1,053.00â–²(8.56% Upside)
Action:reiterated
Date:09/15/26

The score is driven primarily by solid underlying financial resilience (notably the very strong, low-leverage balance sheet) and a very constructive earnings-call outlook pointing to accelerating U.S. growth and meaningful medium-term profit uplift. Offsetting these positives are weak current technical momentum and a high P/E that leaves less room for near-term execution risk, especially given recent margin compression and cash-flow volatility.

Positive Factors
Very low leverageVery low leverage gives Fever-Tree substantial financial resilience and flexibility. It reduces balance-sheet risk, supports continued investment in marketing and innovation, and leaves capacity to fund growth or return surplus cash without relying heavily on borrowing.
Negative Factors
Revenue and margin pressureRecent top-line contraction and lower margins weaken the quality of earnings compared with earlier peak years. Unless growth and pricing improve, reduced profitability can constrain reinvestment, make earnings more sensitive to costs, and limit operating leverage.

Fevertree Drinks (FEVR) vs. iShares MSCI United Kingdom ETF (EWC)

-5%0%5%10%15%20%25%30%35%GB:FEVR+28.92%EWC+18.67%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
GBP 1.39B
Dividend Yield
1.80%
Average Volume (3M)
477.46K
Price to Earnings (P/E)
45.0
Beta (1Y)
1.14
Revenue Growth
1.74%
EPS Growth
2.83%
Country
UK
Employees
285
Sector
Consumer Defensive
Sector Strength
62
Industry
Beverages - Non-Alcoholic

Fevertree Drinks Business Overview & Revenue Model

Company Description

Fevertree Drinks Plc, together with its subsidiaries, specializes in crafting and distributing premium mixer beverages across the United Kingdom, the United States, Europe, and other international markets. Its diverse product portfolio includes popul...

How the Company Makes Money

Fever-Tree makes money primarily by selling branded premium mixers (e.g., tonic water, ginger beer, soda water and other carbonated mixers) to customers in different channels and geographies. Revenue is generated from the invoiced sale of finished go...

Fevertree Drinks Earnings Call Summary

Earnings Call Date:Sep 10, 2026(Q2-2026)|% Change Since:19.51%|Next Earnings Date:Mar 30, 2027
Earnings Call SentimentPositive

The call was strongly positive. Management reported broad-based first-half growth, improving margins and EPS, accelerating U.S. momentum, successful diversification, strong cash generation, and confidence in a circa 60% EBITDA uplift over the next two years. The main challenges were the expected short-term U.S. margin impact from elevated marketing investment, the GBP 2.6 million EPR provision, U.K. on-trade challenges, European revenue phasing, and delayed working-capital benefits from U.S. onshoring.

Positive Updates

Strong First-Half Group Performance
Brand revenue increased by 8% at constant currency, with growth across every key region. The U.S. grew 11%, Europe grew 10%, the U.K. returned to growth, and the rest of the world made good progress.

Negative Updates

U.S. EBITDA Margin Decline
U.S. EBITDA margin reduced as expected, largely reflecting up-weighted marketing investment. Management said incremental U.S. marketing investment is expected to moderate to more typical levels over the medium term.

Company Guidance

For FY 2026, Fever-Tree expects U.S. revenue growth to accelerate as the year progresses, the rest of the group to deliver good underlying growth, reported revenue in Europe to be impacted as phasing benefits from the first half of the year unwind, and EBITDA to be in line with expectations; U.S. tariff refunds received in the second half will offset the full-year impact of the incremental GBP 2.6 million EPR provision, working capital will be similar year-on-year and significantly below historic levels, and the company remains confident of delivering high teens, 20% growth in the U.S. next year, with U.S. and group profitability expected to see a step change in 2027 and 2028, supporting consensus expectations of the circa 60% uplift in EBITDA over the next two years and at least GBP 100 million of free cash flow across 2027 and 2028; group EBITDA margin is expected to move from about 12.5% this year to high 14%-15%.

Fevertree Drinks Financial Statement Overview

Summary

Balance sheet strength (very low leverage; debt-to-equity ~0.02) supports resilience, but operating trends are mixed: revenue declined in 2025 (~-4.4%) and margins are well below 2020–2021 peaks. Cash flow is positive but inconsistent, including a weak 2023 and a sharp free-cash-flow decline in 2025.

Income Statement

62Positive

Balance Sheet

88Very Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue345.80M325.00M368.50M364.40M344.30M311.10M
Gross Profit106.80M107.30M138.40M109.00M118.80M130.90M
EBITDA38.80M36.90M45.70M30.80M37.20M60.60M
Net Income25.20M22.60M24.40M15.40M24.90M44.60M
Balance Sheet
Total Assets266.00M287.00M321.90M313.70M311.60M336.10M
Cash, Cash Equivalents and Short-Term Investments68.00M91.10M96.00M59.90M95.30M166.20M
Total Debt3.80M3.80M12.10M15.20M16.90M2.90M
Total Liabilities64.70M63.90M75.20M75.90M72.40M54.50M
Stockholders Equity201.30M223.10M246.70M237.80M239.20M281.60M
Cash Flow
Free Cash Flow31.30M30.30M56.10M-13.40M1.40M42.20M
Operating Cash Flow35.60M33.60M70.20M-3.80M8.50M46.80M
Investing Cash Flow-3.70M13.10M-10.80M-9.60M-10.00M-4.30M
Financing Cash Flow-94.10M-51.20M-23.60M-23.10M-70.70M-19.30M

Fevertree Drinks Technical Analysis

Technical Analysis SentimentPositive
Last Price970.00

Price Trends

50DMA880.20Positive
100DMA852.48Positive
200DMA835.88Positive

Market Momentum

MACD21.37Negative
RSI65.12Neutral
STOCH84.82Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:FEVR, the sentiment is Positive. The current price of 970.00 is above the 20-day moving average (MA) of 935.28, above the 50-day MA of 880.20, and above the 200-day MA of 835.88, indicating a bullish trend. The MACD of 21.37 indicates Negative momentum. The RSI at 65.12 is Neutral, neither overbought nor oversold. The STOCH value of 84.82 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:FEVR.

Fevertree Drinks Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

GB:FEVR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:NICLGB:NICL82OutperformGBP 389.46M16.3824.74%3.65%2.73%37.06%
GB:CCHGB:CCH72OutperformGBP 15.85B18.8925.10%2.35%12.76%12.70%
GB:BAGGB:BAG70OutperformGBP 679.72M14.9013.40%3.12%6.88%-5.66%
GB:FEVRGB:FEVR64NeutralGBP 1.06B44.9711.88%1.80%1.74%2.83%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
GB:CDGPGB:CDGP55NeutralGBP 82.54M234.210.97%―22.07%―
GB:CCRGB:CCR52NeutralGBP 394.12M111.520.81%4.52%-2.97%-79.32%

* Consumer Defensive Sector Average

Performance Comparison

-20%0%20%40%GB:FEVRGB:BAGGB:CCHGB:NICLGB:CCRGB:CDGPDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:FEVR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:FEVRFevertree Drinks PLC970.00212.7228.09%
GB:BAGA G Barr611.00-8.36-1.35%
GB:CCHCoca Cola HBC4350.00876.7825.24%
GB:NICLNichols plc1065.00104.9210.93%
GB:CCRC&C Group Plc107.00-14.81-12.16%
GB:CDGPChapel Down Group plc44.506.5017.11%

Fevertree Drinks Corporate Events

Other

Fever-Tree Director David Lapp Buys 23,800 Shares in Insider Deal

Positive
Oct 22, 2026

Fever-Tree Drinks has disclosed that non-executive director David Lapp purchased 23,800 ordinary shares in the company on 20 October 2026 at an average price of £9.355 per share. The London Stock Exchange transaction, classified as a PDMR dealing, si...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Fever-Tree Launches Share Buyback and Plans Share Cancellation

Positive
Oct 20, 2026

Fevertree Drinks plc has executed a series of share buybacks between 12 and 16 October 2026 on the London Stock Exchange’s main market and AIM, purchasing ordinary shares at volume‑weighted average prices ranging from about 877p to 916p. The transact...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Fever-Tree Launches Share Buyback and Plans Cancellation of Repurchased Stock

Positive
Oct 13, 2026

Fevertree Drinks plc has undertaken a share buyback programme, purchasing a series of ordinary shares on the London Stock Exchange’s main market and AIM between 5 and 9 October 2026 through its broker Investec Bank. The transactions were executed at...

Business Operations and StrategyStock Buyback

Fevertree Cancels Shares After Buyback on London Markets

Positive
Oct 6, 2026

Fevertree Drinks has repurchased a series of ordinary shares on the London Stock Exchange’s main market and AIM between 28 September and 2 October 2026 under the authority granted at its 2025 AGM. The transactions, executed by Investec Bank, were car...

Regulatory Filings and Compliance

Fever-Tree Confirms Total Voting Rights Following Share Capital Update

Neutral
Oct 1, 2026

Fever-Tree has confirmed that its total issued share capital stands at 110,563,655 ordinary shares of 0.25p each, with one voting right attached to every share and no shares held in treasury. As a result, the total number of voting rights in the comp...

Business Operations and StrategyStock Buyback

Fever-Tree Cancels Shares After Late-September Buyback

Positive
Sep 29, 2026

Fevertree Drinks plc has executed a share buyback, purchasing a series of ordinary shares on the London Stock Exchange’s main market (XLON) and AIM (AIMX) between 21 and 25 September 2026. The trades were carried out via its broker Investec Bank, at...

Business Operations and StrategyStock Buyback

Fever-Tree cancels newly repurchased shares in latest buyback

Positive
Sep 22, 2026

Fevertree Drinks plc has repurchased a series of its own ordinary shares on U.K. venues, including the London Stock Exchange main market and AIM, between 14 and 18 September 2026. The buyback, executed via Investec Bank under previously granted share...

Business Operations and StrategyStock Buyback

Fever-Tree Moves to Cancel Shares After Targeted Buyback

Positive
Sep 15, 2026

Fever-Tree Drinks has moved to buy back its own shares, purchasing ordinary stock through Investec Bank between 7 and 11 September on the London Stock Exchange’s main market and AIM. The programme, executed under shareholder authority granted at the...

Business Operations and StrategyRegulatory Filings and Compliance

Fever-Tree chair boosts stake with share purchase on London market

Positive
Sep 14, 2026

Fever-Tree, the premium mixers producer, reported that its non-executive chair, Domenic De Lorenzo, has increased his stake in the company through a share purchase on the London Stock Exchange. He acquired 44,674 ordinary shares at an average price o...

Other

Fever-Tree Chair Increases Stake with Share Purchase

Positive
Sep 14, 2026

Fever-Tree Drinks reported that its Non-Executive Chair, Domenic De Lorenzo, has acquired 44,674 ordinary shares in the company on the London Stock Exchange. The shares were purchased on 11 September 2026 at an average price of £7.7955, in a transact...

Business Operations and StrategyStock BuybackFinancial Disclosures

Fevertree lifts revenues and earnings as U.S. and U.K. growth gather pace

Positive
Sep 10, 2026

Fevertree Drinks reported interim results for the six months to 30 June 2026 showing Fever-Tree brand revenue up 8% at constant currency to £183.6 million, with growth across all regions and record retail market share in ginger beer and tonic. The co...

Business Operations and StrategyStock Buyback

Fever-Tree Moves to Cancel Shares After Early September Buyback

Positive
Sep 8, 2026

Fevertree Drinks plc has repurchased a series of ordinary shares on both the London Stock Exchange and AIM between 1 September and 4 September 2026 under authority granted at its 2025 AGM. The trades, executed via broker Investec Bank, were carried o...

Business Operations and StrategyStock Buyback

Fever-Tree Cancels Shares After Late-August Buyback Spree

Positive
Sep 2, 2026

Fevertree Drinks has launched a share buyback programme, purchasing tens of thousands of ordinary shares on the London Stock Exchange and AIM between 24 and 28 August 2026 at volume-weighted average prices around 851–860 pence. The company has stated...

Regulatory Filings and Compliance

Fever-Tree Clarifies Total Voting Rights and Share Capital Structure

Neutral
Sep 1, 2026

Fever-Tree Drinks has confirmed that its total issued share capital comprises 111,504,742 ordinary shares, each carrying one voting right, and that it holds no shares in treasury. The declaration sets the official total number of voting rights at 111...

Business Operations and StrategyStock Buyback

Fevertree Drinks to Cancel Shares After August Buyback Programme

Positive
Aug 25, 2026

Fevertree Drinks plc has initiated a share buyback programme, purchasing a series of ordinary shares on the London Stock Exchange and AIM between 17 August and 21 August 2026 through its broker Investec Bank. The transactions were executed under shar...

Business Operations and StrategyStock Buyback

Fever-Tree Launches Share Buyback and Plans Cancellation of Repurchased Stock

Positive
Aug 18, 2026

Fevertree Drinks plc has repurchased a series of ordinary shares between 10 and 14 August 2026 on the London Stock Exchange’s main market and AIM, acting under a previously approved shareholder authority. The trades, executed via Investec Bank, were...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 15, 2026